Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Howe

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Virology|July 1, 1989
Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigenT N Jelsma, J A Howe, J S Mymryk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapyJ A Howe, G W Demers, D E Johnson, et al.
Journal of Environmental Management|February 11, 2025
Emergency mass disposal of milk: Options and considerationsA Mahdaviarab, K Pahlavanyali, R Cheng, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 7, 2001
Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude miceC M Ahmed, K N Wills, B J Sugarman, et al.
Virology|April 1, 1988
Use of deletion and point mutants spanning the coding region of the adenovirus 5 E1A gene to define a domain that is essential for transcriptional activationT N Jelsma, J A Howe, C M Evelegh, et al.
Nature Biotechnology|November 2, 2001
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacyM Ramachandra, A Rahman, A Zou, et al.
Cancer Gene Therapy|November 1, 2001
Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancersC M Iqbal Ahmed, D E Johnson, G W Demers, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Virology|July 1, 1989
Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigenT N Jelsma, J A Howe, J S Mymryk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapyJ A Howe, G W Demers, D E Johnson, et al.
Journal of Environmental Management|February 11, 2025
Emergency mass disposal of milk: Options and considerationsA Mahdaviarab, K Pahlavanyali, R Cheng, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 7, 2001
Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude miceC M Ahmed, K N Wills, B J Sugarman, et al.
Virology|April 1, 1988
Use of deletion and point mutants spanning the coding region of the adenovirus 5 E1A gene to define a domain that is essential for transcriptional activationT N Jelsma, J A Howe, C M Evelegh, et al.
Nature Biotechnology|November 2, 2001
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacyM Ramachandra, A Rahman, A Zou, et al.
Cancer Gene Therapy|November 1, 2001
Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancersC M Iqbal Ahmed, D E Johnson, G W Demers, et al.
Pageof 2